PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $201,000 | -9.9% | 3,770 | -1.3% | 0.03% | -3.6% |
| Q2 2022 | $223,000 | -19.8% | 3,818 | +4.9% | 0.03% | -6.7% |
| Q1 2022 | $278,000 | +24.1% | 3,639 | -9.1% | 0.03% | +15.4% |
| Q3 2021 | $224,000 | -7.4% | 4,005 | +0.4% | 0.03% | -10.3% |
| Q2 2021 | $242,000 | +1.3% | 3,988 | +17.1% | 0.03% | -6.5% |
| Q1 2021 | $239,000 | +9.1% | 3,405 | -7.0% | 0.03% | 0.0% |
| Q4 2020 | $219,000 | – | 3,663 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |